Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 2,624 | 1,437 | 1,163 | 1,222 | 1,576 |
| Operating Income | -2,624 | -1,437 | -1,163 | -1,222 | -1,576 |
| Other Income | 6 | 7 | 27 | 72 | 60 |
| Pre-tax Income | -2,618 | -1,430 | -1,136 | -1,150 | -1,516 |
| Net Income Continuous | -2,618 | -1,430 | -1,136 | -1,150 | -1,516 |
| Net Income | $-2,618 | $-1,430 | $-1,136 | $-1,150 | $-1,516 |
| EPS Basic Total Ops | -0.08 | -0.06 | -0.05 | -0.05 | -0.09 |
| EPS Basic Continuous Ops | -0.09 | -0.06 | -0.05 | -0.05 | -0.08 |
| EPS Diluted Total Ops | -0.08 | -0.06 | -0.05 | -0.05 | -0.09 |
| EPS Diluted Continuous Ops | -0.09 | -0.06 | -0.05 | -0.05 | -0.08 |
| EBITDA(a) | $-2,623 | $-1,436 | $-1,157 | $-1,208 | $-1,562 |